Vir reports Week 96 SOLSTICE data, ECLIPSE program fully enrolled, VIR-5500 expansion underwayAug 5Quarterly updateVir Biotechnology, Inc.VIR-5500
Mirum raises 2026 sales guidance, volixibat gets FDA breakthrough status for PSCAug 5Quarterly updateMirum Pharmaceuticals, Inc.volixibat
Gilead reports Q2 2026 results with three FDA approvals, three positive Phase 3 readoutsAug 4Quarterly updateGilead Sciences
Sign inSign in